MedTrace Logo

A Pilot Study of Dietary Chloride Supplementation on Cardiorenal Function in Heart Failure

NCT02031354 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-06-27

No results posted yet for this study

Summary

The purpose of this study is to determine if administration of supplemental chloride in the form of lysine chloride to patients with congestive heart failure will affect their neurohormonal profile as well as response to diuretics.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lysine Chloride

Administration of 21g of lysine chloride (7g three times daily) for a period of time of 3 days

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Jeffrey M Testani, MD/MTR · Yale University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02031354 on ClinicalTrials.gov